Circulating Tumor Cell Detection In Epithelial Ovarian Cancer Using Dual-Component Antibodies Targeting EpCAM And FRα.
Na LiHao ZuoLuojun ChenHuali LiuJin ZhouYi YaoBin XuHong-Yun GongYiming WengQinyong HuQibin SongMin PengYanxiang ChengPublished in: Cancer management and research (2019)
The combination of FRα and EpCAM is feasible as a CTC capture target of CTC detection in patients with EOC.